Projects per year
Search results
-
Not started
Developing interferon epsilon as a novel immunotherapy for ovarian cancer: identification of an optimal formulation for enhanced efficacy and tolerability.
Campbell, N. (Primary Chief Investigator (PCI)), Hertzog, P. (Chief Investigator (CI)), Gearing, J. (Associate Investigator (AI)) & Ho, G.-Y. (Associate Investigator (AI))
1/07/25 → 30/06/28
Project: Research